1.
Vannucchi AM, Boekhorst PAW te, Harrison CN, He G, Caramella M, Niederwieser D, Boyer-Perrard F, Duan M, Francillard N, Molloy B, Wroclawska M, Gisslinger H. EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis. Haematologica [Internet]. 2019Apr.30 [cited 2026Nov.8];104(5):947-54. Available from: https://haematologica.org/article/view/8897